Vollesen ALH - Search Results

1

S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation?

Snoer AH, Vollesen ALH, Beske RP, Guo S, Hoffmann J, Jørgensen NR, Martinussen T, Ashina M, Jensen RH. Snoer AH, et al. Among authors: vollesen alh. Headache. 2020 Sep;60(8):1569-1580. doi: 10.1111/head.13864. Epub 2020 Jun 16. Headache. 2020. PMID: 32548854 Clinical Trial.

2

Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.

Vollesen ALH, Snoer A, Beske RP, Guo S, Hoffmann J, Jensen RH, Ashina M. Vollesen ALH, et al. JAMA Neurol. 2018 Oct 1;75(10):1187-1197. doi: 10.1001/jamaneurol.2018.1675. JAMA Neurol. 2018. PMID: 29987329 Free PMC article. Clinical Trial.

3

Calcitonin-gene related peptide and disease activity in cluster headache.

Snoer A, Vollesen ALH, Beske RP, Guo S, Hoffmann J, Fahrenkrug J, Jørgensen NR, Martinussen T, Jensen RH, Ashina M. Snoer A, et al. Among authors: vollesen alh. Cephalalgia. 2019 Apr;39(5):575-584. doi: 10.1177/0333102419837154. Epub 2019 Mar 9. Cephalalgia. 2019. PMID: 30854880 Clinical Trial.

4

The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache.

Vollesen ALH, Snoer A, Chaudhry B, Petersen AS, Hagedorn A, Hoffmann J, Jensen RH, Ashina M. Vollesen ALH, et al. Cephalalgia. 2020 Nov;40(13):1474-1488. doi: 10.1177/0333102420940689. Epub 2020 Sep 22. Cephalalgia. 2020. PMID: 32962406 Clinical Trial.

5

Corrigendum to: PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.

Pellesi L, Chaudhry BA, Vollesen ALH, Snoer AH, Baumann K, Skov PS, Jensen RH, Ashina M. Pellesi L, et al. Among authors: vollesen alh. Cephalalgia. 2022 Jul;42(8):NP1. doi: 10.1177/03331024221076702. Epub 2022 May 12. Cephalalgia. 2022. PMID: 35546581 No abstract available.

6

PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.

Pellesi L, Chaudhry BA, Vollesen ALH, Snoer AH, Baumann K, Skov PS, Jensen RH, Ashina M. Pellesi L, et al. Among authors: vollesen alh. Cephalalgia. 2022 Jul;42(8):687-695. doi: 10.1177/03331024211056248. Epub 2021 Nov 25. Cephalalgia. 2022. PMID: 34822741 Clinical Trial.

7

Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine.

Vollesen ALH, Amin FM, Ashina M. Vollesen ALH, et al. Neurotherapeutics. 2018 Apr;15(2):371-376. doi: 10.1007/s13311-017-0596-x. Neurotherapeutics. 2018. PMID: 29464574 Free PMC article. Review.

8

PACAP38 in human models of primary headaches.

Ashina H, Guo S, Vollesen ALH, Ashina M. Ashina H, et al. Among authors: vollesen alh. J Headache Pain. 2017 Nov 23;18(1):110. doi: 10.1186/s10194-017-0821-3. J Headache Pain. 2017. PMID: 29453754 Free PMC article. Review.

9

PACAP38: Emerging Drug Target in Migraine and Cluster Headache.

Vollesen ALH, Ashina M. Vollesen ALH, et al. Headache. 2017 May;57 Suppl 2:56-63. doi: 10.1111/head.13076. Headache. 2017. PMID: 28485845 Review.

10

Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine.

Guo S, Vollesen ALH, Olesen J, Ashina M. Guo S, et al. Among authors: vollesen alh. Pain. 2016 Dec;157(12):2773-2781. doi: 10.1097/j.pain.0000000000000702. Pain. 2016. PMID: 27842045

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters